Mitsubishi UFJ Trust & Banking Corp Has $40.27 Million Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Mitsubishi UFJ Trust & Banking cut its stake in HCA by 54.6%, selling 103,836 shares in Q4 and retaining 86,256 shares valued at about $40.27 million.
• HCA’s Q1 slightly missed EPS ($7.15 vs. $7.19 est.) with revenue roughly in line at $19.11 billion; management set FY2026 guidance of 29.10–31.50 EPS while analysts have trimmed price targets (consensus ~$520.55), pressuring the stock.
• Insiders have sold about 15,214 shares (~$7.8 million) in the last 90 days, the company announced a proposed public offering of senior notes, and it pays a quarterly dividend of $0.78 (annual yield ~0.7%).

Mitsubishi UFJ Trust & Banking Corp lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 54.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 86,256 shares of the company's stock after selling 103,836 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp's holdings in HCA Healthcare were worth $40,269,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of HCA. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $29,000. Harbor Capital Advisors Inc. lifted its position in HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company's stock valued at $32,000 after acquiring an additional 34 shares in the last quarter. JPL Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $33,000. Finally, Aventura Private Wealth LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $34,000. 62.73% of the stock is currently owned by institutional investors.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Stockholders reaffirmed HCA's board and governance at the April 23 annual meeting — removes near‑term activist/governance uncertainty and supports continuity of management strategy. HCA Healthcare Stockholders Reaffirm Board and Governance Structure
• Positive Sentiment: Management highlights improvements in revenue‑cycle performance (CFO commentary) that are contributing to margin resilience despite rising denials/underpayments — a constructive operating tailwind. HCA’s strengthened revenue cycle paying dividends, CFO says
• Neutral Sentiment: Company announced a proposed public offering of senior notes — proceeds for general corporate purposes and possible refinancing; watch pricing and size for balance‑sheet/interest‑cost implications. HCA Announces Proposed Public Offering of Senior Notes
• Neutral Sentiment: Local operational news: new $231M Florida hospital opening in May and a Gulf Coast NICU reunion — positive for regional capacity/brand but not material near‑term drivers. $231M HCA Florida hospital to open in May HCA Gulf Coast Hospital NICU reunion for patients & families
• Neutral Sentiment: Executive hire: Cynthia Cifuentes‑Finkel named SVP of Marketing & Corporate Affairs (effective June 8) — supports communications/brand, immaterial to near‑term financials. HCA Healthcare Names Cynthia Cifuentes‑Finkel SVP
• Negative Sentiment: Analysts across the street cut price targets after Q1: multiple firms lowered PTs (examples: Bernstein to $503, Oppenheimer to $520, TD Cowen/Leerink to ~$500, RBC/Truist/Stephens also trimmed). The volume of PT trims amplifies downward pressure on the stock despite several banks keeping Buy/Outperform stances. Bernstein adjusts price target on HCA
• Negative Sentiment: Policy/revenue hit: the lapse in ACA subsidy funding reduced Q1 results by about $150M — a tangible near‑term earnings drag referenced in coverage. ACA subsidy lapse cost HCA Healthcare $150M in Q1
• Negative Sentiment: Analysts trimmed forward forecasts after Q1 in several writeups (sales roughly in line but EPS slightly missed), increasing near‑term uncertainty around estimates and supporting the sell‑side PT resets. These Analysts Slash Their Forecasts On HCA Healthcare After Q1 Results

Analysts Set New Price Targets

HCA has been the subject of several research analyst reports. Oppenheimer decreased their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an "outperform" rating for the company in a research note on Monday. JPMorgan Chase & Co. raised their price target on shares of HCA Healthcare from $420.00 to $535.00 and gave the stock a "neutral" rating in a research note on Friday, February 20th. Weiss Ratings restated a "buy (b)" rating on shares of HCA Healthcare in a research note on Friday, March 27th. Wells Fargo & Company decreased their price target on shares of HCA Healthcare from $481.00 to $436.00 and set an "equal weight" rating for the company in a research note on Monday. Finally, Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an "outperform" rating for the company in a report on Monday. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $520.55.

Insider Activity

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 15,214 shares of company stock valued at $7,797,595. 1.50% of the stock is owned by company insiders.

HCA Healthcare Trading Down 3.3%

HCA opened at $430.99 on Wednesday. The company has a 50 day moving average of $501.51 and a 200 day moving average of $486.12. The company has a market cap of $96.36 billion, a PE ratio of 14.82, a price-to-earnings-growth ratio of 1.50 and a beta of 1.36. HCA Healthcare, Inc. has a 12 month low of $329.72 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the business posted $6.45 earnings per share. The firm's quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 30.06 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.